Parenteral Drug Association, Inc.
Bethesda, MD
- UEI
- KM95H38J3DR9
- CAGE
- 4Y5L2
- Primary NAICS
- 813920 Professional Organizations
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 4350 East West Highway #600, Bethesda, MD 20814, USA
- Website
- pda.org
- Founded
- 1946
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 86 Membership Organizations
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $74,916 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $74,916 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Education and training program for outsourcing facility industry - PDA global headquarters RFA-FD-23-029 bethesda… | FDA Office of Acquisition and Grant Services | $5,750,000 |
Similar vendors
About the company
Parenteral Drug Association, Inc., doing business as Parenteral Drug Association Inc., is a global provider of science, technology, and regulatory information for the pharmaceutical and biopharmaceutical communities. It is a non-profit organization registered as a corporate entity and foundation.
Parenteral Drug Association Inc. has primarily served as a subcontractor on federal contracts related to compounded drugs and the FDA's Compounding Quality Center of Excellence. It has been a subcontractor to prime contractor Deloitte Consulting LLP on multiple contracts awarded by the Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS). The specific descriptions of the subcontract work are not provided, but they appear to involve support for the FDA's oversight and regulation of compounded drugs.
Parenteral Drug Association Inc. has received one prime federal grant award from the FDA within HHS. This $1.75 million cooperative agreement under the Food and Drug Administration Research program (CFDA 93.103) funds an education and training program for the outsourcing facility industry from 2023 to 2027. The program will provide instructor-led live virtual and in-person training, self-guided online interactive training, and logistical support focused on current good manufacturing practices (CGMPs) for outsourcing facilities that compound drugs. The goal is to establish a sustainable training program for the FDA's Compounding Quality Center of Excellence.
Quick answers
Is Parenteral Drug Association, Inc. registered in SAM.gov?
Yes. Parenteral Drug Association, Inc.'s SAM.gov registration is active through December 4, 2026.
What is Parenteral Drug Association, Inc.'s CAGE code?
Parenteral Drug Association, Inc.'s CAGE code is 4Y5L2, and its Unique Entity ID (UEI) is KM95H38J3DR9.
How much has Parenteral Drug Association, Inc. received in federal contracts?
Federal contracts obligated $74,916 to Parenteral Drug Association, Inc. in fiscal years 2023 through 2027.
What is Parenteral Drug Association, Inc.'s most recent federal award?
Parenteral Drug Association, Inc.'s most recent federal contract award is Parenteral drug association/food and drug administration (PDA/FDA) joint regulatory conference 2026 - EO 14398 (75F40126P00266), from Food and Drug Administration, on September 14, 2026.
On GovTribe
See Parenteral Drug Association, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors